Palkowitsch P, Fursenko V, Liu A, Hofmann B, Klemens M. The QUANTI OBR Phase 3 trial investigating  gadoquatrane for contrast-enhanced MRI of the body with up to 60% less gadolinium. In: Proceedings of the Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition, Cape Town, South Africa. Program #567-06-003.